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  TO	  EVERYONE	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       Somewhere, something incredible is waiting to be known 






Fluorescence microscopy is a powerful technique used in many biological laboratories. It is 
often used as an illustrative tool but in combination with manual efforts, valuable 
quantitative results can also be obtained. The potential of automated fluorescence 
microscopy has been clearly shown by the high-content and high throughput studies 
performed in the pharmaceutical industry and more recently in specialized high 
throughput imaging facilities. Computer controlled image capture and analysis not only 
scales up the actual image capture process and data production it also brings an important 
level of objectiveness into microscopy, a field otherwise suffering from an inherent human 
bias in the selection of which objects to study. There is a growing need for the technique 
to be available for “everyone”, as a regular microscopy tool in biological laboratories. 
 
This thesis illustrates that the combination of available and affordable techniques allow us 
to develop automated microscopy methods, including automated capture and image 
analysis routines that can be applied to answer different biological questions. We show that 
a visual programming language enable us to make flexible applications for automated 
microscopy, without detailed knowledge of complex computer languages (Paper I, Paper 
III - Paper VI). 
 
Using our automated fluorescence imaging and analysis method, in combination with a 
fluid dispenser robot for drug printing, we have developed an assay for high throughput 
drug sensitivity testing. In Paper III, we studied the effect of 29 different cytostatic drugs 
on 17 different lymphoblastoid cell lines. These cell lines are good in vitro models for the 
post-transplant lymphoproliferative disease (PTLD), and the aim of this study was to 
characterize which drugs would be optimal in the treatment of these patients. Summarizing 
the effect of each drug on all 17 LCLs, we identified epirubicin and paclitaxel as drugs that 
were highly effective (even at low concentrations). The same microscopy method was 
applied in combination with an analysis program that could identify and count 
differentially labelled cells in co-cultures. Using this approach, we could characterize which 
cytostatic drugs affect NK cell cytotoxicity negatively (Paper IV). Our data suggested that 
chemotherapy protocols including proteosome inhibitors (such as bortezomib) or anti-
microtubule drugs (paclitaxel, docetaxel and vinblastine) may interfere with NK cell-based 
immunotherapy, if applied simultaneously. Taken together, these two studies suggested 
that our drug sensitivity test might prove useful in assisting the design of optimal and 
individualized treatment protocols for cancer patients. 
 
In Paper V and VI, we have applied the technique in an approach to study neighbour 
suppression by fibroblasts on tumor cell proliferation, in an attempt to mimic in vitro a 
possible microenvironmental control function in vivo. These two studies demonstrated that 
the culture of tumor cells on monolayer of primary fibroblasts, might lead to either growth 
stimulation or growth inhibition of tumor cells. Fibroblasts derived from the prostate of 
patients diagnosed with prostate carcinoma (potential CAFs) were the least inhibiting, and 
occasionally even promoting tumor cell proliferation. However, fibroblasts derived from 
the skin of pediatric patients were highly represented in the group of the most inhibitory 
fibroblasts. Our high-throughput study, with over 500 heterotypic cell combinations, with 
four independent measurements for each sample and individual counting of each tumor 
cell, indicated that the effect of fibroblasts on tumor cell proliferation was predominantly 
inhibitory. The technique allowed us to identify fibroblasts with consistently high and with 
consistently low inhibitory capacity. These are valuable fibroblasts to use in further studies 
to understand the mechanism behind inhibition and its possible clinical relevance. In Paper 
VI we specifically investigated the role of the structure of the fibroblast monolayer. We 
found that it was clearly not sufficient to have the inhibitory fibroblasts present in the 
mixed cell culture but that they also had to form a confluent and sufficiently matured, 
intact monolayer to exert the inhibitory effect. Our data suggested that structured 
accumulation and deposition of extracellular matrix molecules might provide orientation 
dependent behavioral cues to the tumor cell in an un-manipulated, inhibitory monolayer. 
Preliminary gene profiling suggested multiple differences in the signature of inhibitory and 
non-inhibitory fibroblasts. 
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1.1	   METHOD	  DEVELOPMENT	  	  
The first aim of this project was to set-up an automated microscopy platform that was robust 
and flexible enough to run different types of fluorescence based experiments. Using a visual 
programming language and image analysis software, we set out to develop programs that 
could control the microscope hardware and perform automated image capture and image 
analysis. The objective throughout this work was to implement and adjust the method in 




1.2	   METHOD	  APPLICATIONS	  
The technique was specifically adapted for automated imaging and analysis of cells in 384-
well plates. The goal was to develop an automated drug sensitivity assay that could measure 
the effects of cytostatic drugs on tumor cell viability and on NK cell cytotoxicity.  
 
The final aim of this thesis was to characterize the effect of human primary fibroblasts on 
tumor cell proliferation. Using our automated microscopy platform the goal was to optimize 
the technique to measure the proliferation of tumor cells, over time, in co-culture with a large 
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“…biology is undergoing this remarkable transformation from being a purely laboratory-
based science, where each individual work on his or her project, to be an information- 
based science that involves the integration of vast amounts of data across the whole world 
and trying to learn things from this tremendous data set” (Lander 2004) 
 	  
2.1	   AUTOMATION	  IN	  SCIENCE	  
Automated data collection is responsible for a conceptual shift in the science of biology. 
High-throughput methods are not only transforming biology by their production of large 
amounts of new scientific knowledge but also because the technique itself, with the 
production of giant sets of data, changes the requirements on how scientists handle, 
interpret, describe and report data (King, Rowland et al. 2009). The bottleneck is no longer 
the production of experimental data but the actual interpretation of them. We are now 
completely dependent on powerful computers in order to store, process the data and to carry 
out meaningful analysis. The development of new high throughput imaging techniques of 
biological materials is based on the recent development in computational processing power, 
memory handling and data storage capacity (Gonzalez and Woods 2008). There are now 
many examples of successful implementation of high throughput techniques, 
demonstrating their potential, not at least regarding its cost effectiveness. A stunning 
example is found in the reductions in DNA sequencing costs over the last ten years. From 
October 2008 until July 2011 the cost per genome dropped from 8 million USD to 10 000 
USD, due to new high throughput technology (Wetterstrand 2011). 
 
Technical advancements continuously open up new ways how experiments can be 
performed. It is now possible to collect millions of images of cells “blindly” and develop 
hypothesis based on in silico created patterns found by (for example) automated image 
analysis and cluster analysis. The acquisition of new knowledge is no longer limited to the 
traditional way of scientific inquiry that is based on the scheme of i) observation, ii) 
formulation of hypothesis and iii) test the hypothesis by experiment.  Certainly the basis of 
science is still the hypothetico-deductive method and the recording of experiments in 
sufficient detail to enable reproducibility, but it does not necessarily need to be in that 
order. New machine learning tools that have access to large datasets, of both experimental 
data and accumulated knowledge produced by the scientific community, will be able to find 
new correlations, reveal cause and effect relationships in an automated fashion. The 
creation of the first robot scientist Adam, suggested that a computer driven system could 
formulate specific hypothesis upon being initiated by vague instructions by mining large 
databases. Subsequently the system could design and execute experiments to test the series 
of hypotheses, evaluate the results, refine the hypotheses and carry out additional 
experiments that prove or disprove the first set of hypotheses (King, Rowland et al. 2009). 
 
The role of the new generation of scientists will be to design and implement new ways to 
collect reliable raw data on one hand and to extract intellectually meaningful and practically 
useful conclusions on the other hand. Today we witness a revolution where powerful new 
algorithms step-by-step disqualify the various objections against the limits of artificial 
intelligence, among other the famous Lady Lovelace’s Objection that states that computers 
are incapable of originality because machines are incapable of independent learning (“The 
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Analytical Engine has no pretensions whatever to originate anything. It can do whatever we know how to 
order it to perform. It can follow analysis; but it has no power of anticipating any analytical relations or 
truths”- Ada Lovelace 1815-1852) (King, Rowland et al. 2009). 
 
Computers are now able to extract natural laws from raw experimental data in a similar way 
as Kepler´s laws of planetary movements were formulated on the basis of astronomical 
observations (Schmidt and Lipson 2009). 
 
 
2.2	   LIGHT	  MICROSCOPY	  TECHNIQUES	  
Collection of data in this thesis is primarily done using different types of light microscopy 
techniques. The name of the technique is revealing, it originates from the Greek; µικρός 
(mikrós) σκοπεῖν (skopeîn) and can be translated: “to look at small things”. The light 
microscope is an instrument that uses light and lenses to magnify objects that are not 
possible to see with the naked eye. The various light microscopes available for general and 
specialized use in research are all compound microscopes, using multiple lenses for 
magnification. In comparison, a magnifying glass, the simplest form of a microscope, uses 
only one lens. Resolution of a system defines the distance of how close two objects can be 
and still be seen as two separate entities. The resolving power of the human eye is 0,2 mm 
and is determined by the spacing of the photoreceptor cells in the retina. Apart from helping 
us to see small things - the job for a microscope is to improve resolution and contrast. The 
theoretical resolution of a light microscope is 0,2 µm, improving human vision by 1000 times 
(Ross, Kaye et al. 2002). In microscopy, resolution is determined by the diffraction of light, as 
postulated by Ernst Abbe in 1873 (Chi 2009) (Figure 2.1). Resolution depends on the light 
gathering capacity of the lens (defined as the numerical aperture of the objective (NA)) and 
the wavelength of the light. 
     
             
Figure 2.1 Abbe’s law 
        
Thus, resolution gets better with high NA objectives and short wavelengths of light. 
Magnification itself does not contribute to resolution, even though it is often so that 
objectives with high magnification also have high NA. Magnification increases the apparent 
size of an object and affects its intensity. The brightness of an image is proportional to the 
NA and inversely proportional to magnification (North 2006; Goldman, Swedlow et al. 
2010). The thickness of the imaging plane (the depth of focus) gets thinner with high NA-
objectives (Conchello and Lichtman 2005). In the last two decades advancement in applied 
physics has circumvent the limitations of diffraction-limited resolution and it is now possible 
to study object smaller than 20-50 nm (Hell and Wichmann 1994; Gustafsson 2000; 
Heintzmann, Jovin et al. 2002). Perhaps there is no other single device that brought so much 
to biology as the microscope. Since 1675, when Anton van Leeuwenhoek first discovered 
the cells and bacteria under its lenses, until today when we can study the proteins inside living 
cells at the nanometer scale (Eggeling, Ringemann et al. 2009). 
 
The work in this thesis is based on three types of light microscopy techniques: bright-field, 
phase contrast and fluorescence microscopy. 
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2.2.1	  Bright	  field	  microscopy	   	   	  	   	  
In conventional bright-field microscopy the sample is illuminated with transmitted white 
light. The image is the result of different absorption levels of light and light scattering 
throughout the sample, either due to density differences in structures or due to histological 
staining of the specimen. Contrast and quality is limited by the thickness of the sample. 
 
2.2.2	   Phase-­contrast	  microscopy	  
Phase-contrast microscopy shows proportional differences in optical density in a sample. It 
converts sample-induced shifts in the phase of light, to visible intensity differences.  The 
transmitted light will be phase-shifted in the sample due to differences in the refractive 
index. Imposed phase shift in the transmitted light will interfere with the diffracted light 
resulting in the phase contrast image. A phase contrast image show higher contrast than a 
bright-field image but the quality is more limited by the thickness of the sample. 
 
2.2.3	   Fluorescence	  microscopy	  
Fluorescence microscopy allows the visualization of specific and selected structures within a 
sample. The technique is based on the activation of molecules with fluorescence capabilities 
(fluorophores) that have been tagged to structures of interest (Haugland 2005). Fluorophores 
have chromophoric units with electrons organized in such a way that they favour the 
absorption of certain wavelengths of lights. Upon illumination, electrons in the 
chromophoric unit absorb photons with certain energy and will move from their ground 
state to a higher energy level and create a molecule in an excited state. The excited lifetime is 
extremely short and the electrons will fall back down to their ground state emitting the excess 
energy as fluorescence light. Due to energy loss in form of vibration in the excited state, the 
energy of the emitted light will be slightly less and having a longer wavelength than the 
excitation light. The difference between the exciting and emitted wavelengths, known as the 
Stokes shift, is the critical property that makes fluorescence microscopy so powerful 




Figure 2.2 Jablonski energy diagram, simplified (left). Fluorophore absorption and  
emission profiles, with Stokes shift (right). 
 
Under optimal settings, using matching excitation light and fluorophores in combination with 
proper filter set-ups, it is possible to filter out excitation light without blocking emitted 
fluorescence and to see only objects that are fluorescent. Contrast is therefore higher in 
fluorescence microscopy compared to the absorption techniques, such as bright field and 
phase contrast (Lichtman and Conchello 2005). Fluorescence intensity is proportional to the 
number of fluorophores in the excited state and to the illumination intensity. However, the 
excited state and the fluorescence intensity can be saturated with increasing illumination 
intensity (Wolf 2007). Photobleaching is a common phenomenon and potential problem in 
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fluorescence microscopy and it is therefore important to minimize both the illumination 
intensity and its duration. Shut off illumination when it is not needed. Anti-fading agents can 
also be applied to the sample during the staining procedure.  
 
Fluorophores can be added to the specimen in essentially three ways: (i) conjugated to 
antibodies that bind to specific targets, (ii) be part of dyes having inherent specific binding 
(such as nucleic acid stains like Hoechst and DAPI), or (iii) through the introduction of 
fluorescent proteins genetically encoded as a fusion with a cDNA of interest (Lippincott-
Schwartz and Patterson 2003). The discovery and cloning of GFP, the green fluorescent 
protein, found in the Aquaria Victoria jellyfish (Shimomura, Johnson et al. 1962; Prasher, 
Eckenrode et al. 1992) was the starting point for a production and exploration of numerous 
fluorescent proteins with colors that span the whole visible spectrum (Goldman, Swedlow et 
al. 2010). One of these was the red fluorescent protein (DsRed), which was isolated from the 
coral Discosoma. The problems associated with its wild-type tetramer form has recently been 
overcome and its monomeric descendant, mRFP (monomeric red fluorescent protein), is 
together with GFP valuable tools of cell biology, especially in live cell imaging. mRFP has 
minimal emission when excited at wavelengths optimal for GFP which makes these two 
fluorescent protein optimal for multicolor labeling (Campbell, Tour et al. 2002). Fluorescent 
proteins are, because of their endogenous expression, very suitable for live cell imaging. 
Fluorescent lipid molecules and organelle-specific dyes that are cell permeable and 
compatible with living cells are other alternatives for live cell staining (Stephens and Allan 
2003). We have used various labelling techniques; genetic (EGFP and mRFP fusion proteins) 
and chemical organelle-specific dyes (such as Mitotracker or Lysotracker) to ascertain the 
viability and functional integrity of our cells during the experiments presented in this thesis 
(Figure 2.3). 
 
      
 
Figure 2.3 Visualization of cellular organelles in living cells over en extended period of observation (4 
dimensional, confocal time-lapse movies, POC-mini chamber). EGFP-actin (green) and mRFP-
histone H2A (red) in transfected PC3 prostate carcinoma cells, 63X (left). Organelle staining of 
mitochondria (Mitotracker, yellow) and lysosomes (Lysotracker, blue) in a human fibroblast, 100X 
(right). 
 
When working with living cells it is necessary to consider the viability of cells on the 
microscope stage. The energy of photons can cause photodamage and cells are particularly 
sensitive to illumination in the presence of fluorophores, which generate free radicals upon 
photobleaching. Again, limiting the illumination time is vitally important but there are also 
other ways of limiting light-induced damage. Reducing the levels of oxygen and 
supplementing the medium with scavengers such as ascorbic acid (vitamin C) are other 
ways to limit the reactions with oxygen free radicals. It is also important to keep the cellular 
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environment stable, controlling factors such as temperature, pH, CO2 and humidity 
(Stephens and Allan 2003; Frigault, Lacoste et al. 2009).  
 
Wide field fluorescence microscopy provides clear lateral (x- and y-axis) information but only 
limited axial (z-axis) information (North 2006). Because fluorescence light is collected from 
the entire depth of the specimen, the resulting image is the sum of fluorescence signals in 
focus together with un-sharp, out-of-focus signals. For samples thicker than a few 
micrometer or when detailed axial information is needed (for co-localization) other 
techniques will be more optimal to use (see confocal microscopy 2.2.4) (White, Amos et al. 
1987). Deconvolution, a computational technique that restores z-axis information based on 
properties of the imaging system, is an often used and effective way to improve the quality. 
 
Fluorescence microscopy has revolutionized biological imaging, allowing scientists to study 
specific structures, organelles and proteins both inside living and in fixed cells and tissues. 
The result is an amazing world of cellular details – although in an artificially coloured cell 
universe.  
 
2.2.4	   Confocal	  microscopy	  
Confocal microscopy allows the visualization of thin optical sections of a specimen with 
minimal out of focus blur. A series of sections along the z-axis can be collected in order to 
build a Z-stack, which can be rendered to represent a 3D view of the object. The way light 
behaves when it passes through the lenses in a microscope contributes to diffraction-limited 
resolution. Not even illumination of an infinitely small point, that emits fluorescence light, 
will produce an image of a perfect point. The product is rather a blurred point with a “halo”. 
This is called the “Airy disk” and is the result of diffraction of light. The diffraction of light 
does not only have an affect in the xy-direction but also in the z-direction. The Airy disk 
extends in the z-direction as an hourglass shaped light cone. It is the “tails” of this hourglass 
that are reduced using confocal microscopy, restricting the collected fluorescent signal to one 
focus plane (Conchello and Lichtman 2005; Inoue 2006). Lasers, with their coherent and 
narrow beam of light, are used as excitation sources and are scanned as a focused point 
across the sample. The emitted fluorescence is collected through a pinhole before reaching 
the detector. The pinhole allows only light predominantly from the focal plane to reach the 
detector, while rejecting the out-of-focus photons (Lucitti and Dickinson 2006). 
 
Conventional single-point scanning confocal (SPSC) systems uses one pinhole to exclude the 
out-of-focus fluorescence from above and below the sample focus plane (Hammond and 
Glick 2000). The sample is imaged using a single laser beam, focused to a spot that scans 
across the sample. A 2D image is sequentially built up from the point-by-point emitted 
fluorescence and collected through the confocal pinhole and registered by a photomultiplier 
tube (PMT). The scanning time for one image is proportional to the exposure time at each 
point (pixel dwell time) and the total number of points (size of the image). This scanning 
process is thus limited by the exposure time, (typically in the microsecond range) needed to 
collect sufficient amount of fluorescence. Shorter exposure times have to be compensated 
for by increased illumination.  
 
Nipkow spinning disc systems (NSC) parallelize the point scanning process and uses CCD 
camera for detection of an instant confocal image. The confocal microscopy work presented 
in this thesis is produced using Yokogawa Nipkow spinning disc systems. Instead of one 
pinhole, the Yokogawa scanning head (CSU10 and CSU22) has twenty thousand pinholes 
with matching microlenses, producing focused multi-beam illumination and parallelized 
confocal point detection with instant confocal imaging. To overcome the poor transmission 
of the first versions of scanning discs, Yokogawa introduced the microlens-array disc and 
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achieved up to 40% better transmission (Wang, Babbey et al. 2005). The pinholes are 
arranged in such a pattern that when the disc rotates, a given point in the sample is 
illuminated several hundred times per second, allowing lower excitation intensities than 
compared to SPSC systems. Because the intensity in each spot is low and the effective 
quantum efficiency of the CCD camera is higher than that of the photomultiplier tube, disk 
scanners cause less photobleaching and less phototoxicity than SPSC systems (Wang, Babbey 
et al. 2005; Hardin 2006). Wang et al. have shown that the CSU10 system was capable of 
reproducing the highest SNR (signal-to-noise ratio) measured for an SPSC system at 
approximately 1/15th of the rate of photobleaching. Perhaps the only drawback of the 
spinning disc parallelization is that the axial resolution is slightly compromised due to cross-
talk between the high-density foci; 0,71 µm compared to 0,60 µm for the SPSC system 
(100X/NA1.4) (Egner 2002; Wang, Babbey et al. 2005). 
 	  
2.3	   AUTOMATED	  MICROSCOPY/HIGH	  THROUGHPUT	  IMAGING	  
High-throughput techniques have defined the development of modern biology, from flow 
and laser scanning cytometry (cell counting/surface molecule analysis), mass spectrometry 
(protein analysis), microarrays (DNA or protein profiling) to whole genome sequencing 
techniques. Microscopy and imaging has also undergone a transformation towards 
automation, and moved from its traditional purely descriptive function into becoming an 
effective quantitative tool. Line scanners, using transmitted light illumination and a linear 
array of detectors, creating a number of contiguous overlapping image stripes paved the way 
for automated microscopy in pathology. Techniques aiming at the digitization of entire 
microscope slides have led to the emergence of virtual histopathology (Ying and Monticello 
2006). Automated, bias free image capture of large amount of consecutive image tiles and the 
alignment of them into a continuous panorama, which is freely "zoomable" in silico is the 
foundation of virtual microscopy (Leong and McGee 2001; Lundin, Lundin et al. 2004; Lee 
2005; Glatz-Krieger, Spornitz et al. 2006). Automated fluorescence microscopy at low 
resolution is emerging as an alternative to laser scanning cytometers (Varga, Bocsi et al. 
2004). More recently the emergence of the tissue microarray technology has facilitated the 
visualization and analysis of molecular alterations in thousands of tissue specimens in a 
parallel fashion (Kallioniemi, Wagner et al. 2001; Lundberg, Gry et al. 2008). 
 
The time consuming manual microscopy process and the main dilemma in traditional 
microscopy - the inherent human bias in the selection of an image area, has been overcome. 
Meanwhile, a demand for automated, high-resolution, fluorescence microscopy techniques 
has been growing, to match the development the other techniques, and to allow quantitative 
analysis of fluorescence properties (Pepperkok and Ellenberg 2006). The hardware 
prerequisites for such automatic imaging systems are (1) motorization of the microscope 
stage, (2) automatic changing of objectives and/or laser scanner zoom, and (3) switching of 
fluorescence filter and/or laser lines (Conrad, Wunsche et al. 2011). Standard microscopes 
are now being replaced with new purpose-built platforms that enable collection of high-
spatial and high-temporal resolution data (Barbe, Lundberg et al. 2008; Lundberg, Gry et al. 
2008; Dobbie, King et al. 2011).  
 
High-throughput imaging systems should ideally be compatible with many fluorescence-
based assays and they should be completely adapted in terms of both hardware and 
software for fully automated operation (Pepperkok and Ellenberg 2006). Commercial 
systems are often forced to focus on specific aims; ultra-high throughput with limitations in 
magnification and wave-lengths, adaptable for plates and fixed cells on slides but not for 
living cells in chambers, and image analysis restricted to certain processes and 
measurements. The advent of new automated systems with an open software architecture 
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that allow users to develop their own tailor made modules for both capturing and image 
analysis has opened up new ways of performing automated microscopy. A feature of the 
development of a new digital technology, by different microscope manufacturers, was the 
emergence of large number of different digital image formats. Meaningful comparison of 
data from different laboratories on the other hand require standardized handling of digital 
image information. The reaction of the scientific community to this confusion of multiple-
formats was the creation of “The Open Microscopy Environment (OME)”. It is part of a 
multi-site collaborative effort among academic laboratories and a number of commercial 
entities to produce open tools to support data management for biological microscopy 





Figure 2.4 Early high-throughput microscopy. “A scientific conversazione with microscopes 
provided to view microscopic objects. Such events attracted a large public” (Oheim 2007). Engraving 
from Illustrated London News 28 April 1855. With permission, Shropshire Museums. 
 
Automated microscopy and high throughput imaging is still challenging and under constant 
development. Scaling up quantitative microscopy for high-content and true high-
throughput screening requires the seamless integration of several advanced techniques, 
apart from the automated image capture. It is important to consider the need to automate 
certain steps in the process, such as sample collection and preparation, liquid handling with 
robotics and the handling of the produced data. Automated image analysis is perhaps the 
most crucial and challenging part. Despite the extensive literature on pattern recognition 
and image segmentation, the expertise has only sporadically made its way into the analysis 
of microscopic images in biological research (Oheim 2007). Recently developed techniques 
takes automated imaging further, towards a transition to intelligent microscopy. It provides 
a machine learning-based module that can be trained by the user to automatically identify 
desired cell states during an unattended, fast, low-resolution pre-scanning mode. Upon 
identification of a cell of interest it can prompt the imaging system to switch mode and run 
a desired high-resolution and high-information-content assay (Conrad, Erfle et al. 2004; 
Conrad, Wunsche et al. 2011). Automated fluorescence microscopy, cell microarray 
platforms, quantitative image analysis and data mining, combined with multivariate 
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statistics and computational modeling, now coalesce to produce a new research strategy 
called systems microscopy (Lock and Stromblad 2010). 
 
One crucial question remains: will automated microscopy continue to mainly be part of 
consortia and imaging centers that combine transversal expertise in a tight and large-scale 
academic–industrial partnership, or will it, via commercial products, or clever and highly 
available (open source) resources make its way into the small- and medium-sized 
laboratories, to fundamentally change the way fluorescence imaging is done today in cell 
biological research? (Oheim 2007). There is clearly a gap to fill - the every day need for 




2.4	   DIGITAL	  IMAGING	  AND	  IMAGE	  ANALYSIS	  
A digital image is a two dimensional array of elements called pixels. The size of each pixel 
and the total number of pixels in an image is dependent on the detector used. In fluorescence 
microscopy it is most common to use cold CCD cameras as the signal-collecting sensor. A 
CCD camera works as an analog to digital converter, converting photons to electrons and the 
value of each pixel corresponds to the number of photons collected. The dynamic range of a 
camera defines the capacity to describe different intensities of signals, a 12 bit camera can 
display 4 096 grey levels.  
 
A basic concept for communication of any kind of information is that received signal equals 
information plus noise, and this is also true regarding images (Fiske 1990). The first step in 
image processing is therefore trying to compensate for noise; defects, imperfections, and 
non-uniformity in the detection (Lo and Puchalski 2008). The aim is to enhance the 
information component of the signal and to reduce the background. There are many 
techniques to reduce background, enhance image quality and automatically analyze objects. 
Below, I will briefly go through some of the most important techniques used in this thesis. 
 
Spatial domain processing refers to image processing based on direct manipulation of pixels 
in the image plane. There are two types of categories of spatial domain image processing, 
intensity transformations and spatial filtering. Intensity transformations, such as contrast 
manipulation and image thresholding operate on single pixels of an image (point processing). 
Spatial filtering techniques perform operations regarding pixels as correlated entities, working 
in a neighbourhood of every pixel in an image (neighbourhood processing) (Gonzalez and 
Woods 2008).  
 
Random noise can be defined as sharp intensity transitions. A smoothing filter effectively 
reduces such noise by replacing every pixel in the image by the average of the intensities 
levels in a neighbourhood, defined by the size of a filter mask. However, if it is important to 
keep edges of objects intact it is better to use a median filter, which works as a good noise-
reducer but with less blurring effect than smoothing filters. A median filter rank the pixel 
values contained in a defined neighbourhood and replaces the central value with the median 
(no new pixels values are created). In contrast to smoothing and median filters, sharpening 
filters highlight transitions in intensity and such filters are extensively used for segmentation 
of objects (Gonzalez and Woods 2008). To separate objects that are touching each other is 
difficult and a constant challenge in image analysis. Watershed algorithms are a powerful tool 
for segmentation (Ross 2011). Point-processing using thresholding sets lower and upper 
threshold values, segmenting the image into features of interest and background, creating a 
binary image. This tool can be used to select objects for quantification. To remove smooth 
continuous backgrounds, a rolling ball background subtraction tool can be used. Here, the 
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image is viewed as a 3D-surface with pixel intensity values interpreted as height values over 
the xy-plane. A structure element, a ball in this case, is rolled across the 3D-surface and 
dependent on its radius it will remove background by flatten out the valleys where it cannot 
reach the lowest points (Gonzalez and Woods 2008). A find maxima tool can be used to 
quantify point-like objects, by determining local maxima of objects (defined by a noise 
tolerance that stand out from the background with a certain value). 
 
2.4.1	   Software	  environment	  to	  create	  image	  capture	  and	  
processing	  tools	  
In this thesis image analysis tools available in the Openlab Automator (Perkin Elmer, USA) 
and in ImageJ have been used for image processing. ImageJ is a public domain image-
processing program, originally developed by Wayne Rasband at NIH 
(http://rsbweb.nih.gov/ij/docs/intro.html). It is an experimental, Java-based system, where 
any user can share plugins and write their own macros designed to answer specific image 
processing questions. ImageJ is free and runs as an online applet or as a downloadable 
application on any computer. There are several other techniques/programs researcher can 
use to create custom-built algorithm for image processing. KNIME is, like Openlab 
Automator, a visible programming language allowing the researcher to design intuitive 
flowcharts that are able to perform complex image processing and analysis tasks without the 
need to write computer code (Quintavalle, Elia et al. 2011). 
 
 
	  2.5	   CANCER	  
Cancer is a global problem with an estimate of 12,7 million people diagnosed in 2008 (Figure 
2.5). In the same year, 7,6 million cancer deaths occurred, which is equivalent to the loss of 
14 lives per minute (Figure 2.6). 56% of the diagnosed cases and 63% of the cancer deaths 
occurred in the economically developing countries of the world (Ferlay, Shin et al. 2008; 
Ferlay, Shin et al. 2010). Worldwide, calculating with an average life expectancy of 68 years, 
one of eight persons will be diagnosed with cancer during their lifetime. In Western 
Europe, where life expectancy is 80 years and the incidence of cancer is high, one of three 
people will be affected by cancer during their life (Klein 2009; CancerResearchUK and 
IARC 2011). The world population is ageing: the global burden of cancer continues to 
increase largely because of the aging factor and growth of the world population, alongside 
with an increasing adoption of cancer-causing behaviors, particularly smoking, in 
economically developing countries (Jemal, Bray et al. 2011). 
 
Cancer is not just one disease, approximately 200 different diagnoses are found in humans. 
The five most common cancer types in the world are, in order, lung, breast, colorectal, 
stomach and prostate cancer. Together they represent almost half the of all cancers cases; 
48,3% or 6,1 million cases (Figure 2.5) (Ferlay, Shin et al. 2008).  
 
2.5.1	  Why	  do	  we	  get	  cancer?	  	  	  
Most cancers trace their origin to a single transformed cell. This single cell resides within a 
body of cells that are more numerous than there are stars in our galaxy (1011 stars in the Milky 
Way galaxy) (Morrison, Wolff et al. 1995). The human body is comprised of around 5-10 
trillion (1013) cells, which all share the same instructions inside their DNA code (Alberts, 
Johansson et al. 2002). In different organs, cells have specific sets of genes activated, which 
allow them to express a repertoire of proteins needed for the proper function of that organ. 
Cells are dependent on each other and on the surrounding environment for their survival. A 
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complex network of signalling orchestrates the activities within and the interplay between 
cells. Each day, 50 – 70 billion (109) cells die due to apoptosis in the average human adult 
(Chen and Lai 2009). To maintain homeostasis many cells will also have to go through 
division.  
 
Cancer is a disease involving changes in the genome of cells and in the surrounding 
environment (Hanahan and Weinberg 2000; Bissell and Radisky 2001). At the single cell level 
cancer has been defined as the consequence of mutations that involves oncogenes with 
dominant gain of function and/or tumor suppressor genes with recessive loss of function. 
A normal cell evolves by multiple stepwise changes (tumor progression) to a neoplastic 
state (Foulds 1954). In order to progress to a tumor, the cell has to acquire certain 
capabilities, defined as the hallmarks of cancer. This multistep process of accumulated 
changes allows normal cells to become tumorigenic and ultimately metastatic (Hanahan and 
Weinberg 2000; Bozic, Antal et al. 2010). 
 
The original six hallmarks of cancer development, as defined by Hanahan and Weinberg 
2000, has as of 2011 been re-defined and accompanied by two more emerging hallmarks 
with potential generality (Hanahan and Weinberg 2011);  
 
1) Sustaining proliferative signaling 
2) Evading growth suppressors 
3) Resisting cell death 
4) Enabling replicative immortality 
5) Inducing angiogenesis 
6) Activating invasion and metastasis 
7) Reprogramming energy metabolism  
8) Evading immune destruction 
 
A tumor is more than just millions of transformed cells. It is a heterogeneous and complex 
tissue, which can even be regarded as a new organ (Bissell and Radisky 2001; Mueller and 
Fusenig 2004; Bissell and Hines 2011). The interactive signalling between the tumor and the 
stroma contributes to the complexity of this tissue (Mueller and Fusenig 2004). Therefore, to 
understand the biology of tumors, it is essential to also look at the different types of 
(ostensibly) normal cells within or in the immediate vicinity of the tumor (the tumor stroma). 
On a “micro-macro” level, the acquired sets of functional capabilities result in the 
autonomous growth of a new tissue that has escaped normal restraints on cell proliferation 
and show varying degrees of fidelity to their precursors and to the original function of the 
organ (Rubin, Strayer et al. 2008). The understanding that the tumor microenvironment and 
tumor stroma is essential for tumorigenesis, has (after many years) now become consensus in 
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Figure 2.5 Estimated number of cancer cases 2008. World: both sexes, all ages  





WORLD	  CANCER	  MORTALITY	  
 
 
Figure 2.6 Estimated number of cancer deaths 2008. World: both sexes, all ages  
(total: 7 564 802). Source: (Ferlay, Shin et al. 2008) 
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2.5.2	  Normal	  stroma	  versus	  tumor	  stroma	  
Genetically abnormal cells define the epithelial parenchyma of carcinomas, whereas recruited 
cells of mesenchymal origin constitute the tumor-associated stroma. The surrounding and 
interwoven stroma provides a connective-tissue framework for the tumor tissue. The stroma 
compartment includes many different cells, including fibroblasts, adipocytes, infiltrating 
immune cells and endothelial cells (Mueller and Fusenig 2004; Weinberg 2008).  
 
Fibroblasts are the main cellular component of the connective tissue and they are found 
embedded in a fibrillar matrix. This matrix, or more correctly the extracellular matrix (ECM), 
is a complex three-dimensional network of macromolecular protein fibers and non-fibrous 
proteoglycans. The ECM is a multitasking unit as it provides architectural structure and 
strength as well as contextual information for cellular communication, adhesion and 
migration (Mueller and Fusenig 2004; Parsonage, Filer et al. 2005). Fibroblasts are 
responsible for the production of many components of the ECM, such as type I, III, V-
collagens and fibronectin. They also contribute to the formation of the basement membrane 
by secreting type IV collagen and laminins (Woodley, Stanley et al. 1988; Chang, Chi et al. 
2002). The laminins are large heterotrimeric glycoproteins that are major components of 
the extracellular matrix (Zagris, Chung et al. 2000). Fibroblasts are key players in the 
connective tissue not only because they synthesize its building blocks, but also because they 
are an important source of proteolytic enzymes such as the family of matrix 
metalloproteinases (MMPs). Through their production of such ECM-degrading proteases 
they also play a crucial role in maintaining ECM homeostasis by regulating ECM turnover 
(Kalluri and Zeisberg 2006). MMPs constitute a family of over 24 members, which 
collectively are capable of degrading virtually all protein components of the ECM (Lynch and 
Matrisian 2002). 
 
For tissues to stay devoted to their function during development, adult tissue remodeling 
and tissue homeostasis depend upon the strict maintenance of a complex spatial and 
temporal dialogue between the epithelium and the cellular and acellular components of the 
tissue stroma (Weaver and Gilbert 2004). Cells communicate with each other and with the 
ECM dynamically, via junctions and receptors (such as the ECM receptor family of integrins) 
hormones and other soluble factors (Varner and Cheresh 1996; Bissell and Hines 2011). In 
addition, fibroblasts also secrete growth factors that direct mesenchymal-epithelial cell 
interactions (Kalluri and Zeisberg 2006). 
 
In undisturbed adult tissues, fibrocytes are post-mitotic resting cells. As part of a regenerative 
response after tissue damage, fibrocytes become metabolically activated fibroblasts and re-
enter the cell cycle. This process is primarily initiated by platelet-derived growth factors 
(PDGF) released from the aggregated thrombocytes at the site of injury. Activated fibroblasts 
are actively engaged in pro-inflammatory signaling and participate in the recruitment of 
immune-effector cells. Fibroblasts are responsible for the replacement of the temporary 
barrier of the wound (the clot) with a permanent scar tissue. Fibroblasts also communicate 
with the damaged epithelial compartment and participate in the regulation of re-epithelization 
through a complex signaling network that involves, amongst others, various members of the 
TGF-ß family. At the later stage of wound healing response, fibroblasts can be converted to 
contractile myo-fibroblasts that are responsible for the contraction of the scar tissue. 
 
In normal tissues, fibrocytes are not directly adjacent to the cells of the parenchyma. The 
basement membrane acts as a barrier separating the epithelium from the surrounding 
stroma, which plays an important role in tissue architecture and compartmentalization 
(Tanjore and Kalluri 2006). The integrity of the basement membrane also defines the 
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tumor microenvironment by providing significant host-derived regulatory signals during 
progression of tumor growth and metastasis (Tanjore and Kalluri 2006). 
 
Cancer initiation, progression, and invasion occur in this complex and dynamic stroma 
microenvironment (Sautes-Fridman, Cherfils-Vicini et al. 2011). The tumor stroma contains 
various fibroblast-like cells of mesenchymal origin e.g. carcinoma-associated fibroblasts 
(CAFs), pericytes/mural cells and vascular smooth muscle cells (Ostman and Augsten 2009). 
CAFs show certain resemblance to contractile myo-fibroblasts. The separation of CAFs from 
normal cell is not a trivial task. Markers that are routinely used to identify CAFs, such as 
alpha-smooth muscle actin (α-SMA), platelet derived growth factor receptor beta (PDGFRß) 
and neuron-glial antigen-2 (NG2), overlap with each other in identifying a mixed 
population of fibroblasts (activated or resting), myofibroblasts, pericytes and vascular 
smooth muscle cells. The S100A4 protein/fibroblast specific protein-1 (FSP1) has been 
identified as a more suitable marker for CAFs (Sugimoto, Mundel et al. 2006). Recent data 
established a functional role for Hedgehog signaling, primarily in the tumor 
microenvironment, where it is involved in myofibroblast differentiation and the induction 
of stroma-derived growth promoting molecules. Since the protumorigenic functions of the 
abundant stromal desmoplasia is typically associated with pancreatic cancer, targeting the 
Hedgehog pathway might prove to be beneficial in the treatment of the disease (Lauth and 
Toftgard 2011). 
 
During the metastatic process, cancer cells migrate through locally different 
microenvironments, including the interstitium, the blood vessel endothelium, the vascular 
system and the tissue at a secondary site. The ability to successfully complete this journey 
and advance towards the formation and growth of a secondary tumor is dependent, in part, 
on the physical interactions and mechanical forces between cancer cells and the 
microenvironment. The physical interactions between a cell and the ECM play a key role in 
allowing cells to migrate from a tumor to nearby blood vessels (Lemaire, Deleu et al. 2011; 
Wirtz, Konstantopoulos et al. 2011). 
 
Both the wound healing process and tumor development involve migratory cell movements. 
Chemotaxis of both tumor cells and stromal cells is an essential component of tumor 
dissemination during progression and metastasis. In fact, chemotaxis is now considered to be 
a potential prognostic marker, a treatment end point and a target of therapeutic intervention 
in cancer (Roussos, Condeelis et al. 2011). Active migration of tumor cells may require 
distinct phenotypic changes that are associated with the loss of epithelial markers 
(dedifferentiation) and gain of mesenchymal markers (epithelial-mesenchymal transition – 
EMT). The EMT transition is a highly conserved cellular program that allows polarized, 
immotile epithelial cells to convert to motile cells with mesenchymal features. This cellular 
program has been observed to underlie many of the tissue remodeling events during 
embryonic development and more recently been associated with cancer invasion and 
metastasis (Yang and Weinberg 2008).  
 
Tumors require vascularization to surpass a certain minimum size (neo-angiogenesis). 
Angiogenesis is one of the hallmarks of cancer. Angiogenesis however is rarely perfect in 
tumors. The imbalance of pro- and anti-angiogenic signaling within tumors often creates an 
abnormal vascular network that is characterized by dilated, tortuous, and hyperpermeable 
vessels. This mess of abnormalities also influences the microenvironment and might fuel 
tumor progression. Moreover, it also leads to a reduction in the efficacy of chemotherapy, 
radiotherapy, and immunotherapy. Pre-clinical studies have shown that anti-vascular 
endothelial growth factor (VEGF) therapy can lead to vascular normalization, with a 
reduction in hyperpermeability, increased vascular pericyte coverage and resulting in a more 
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normal basement membrane and this in combination with chemotherapy leads to 
improved clinical outcomes (Brown, Guidi et al. 1999; Goel, Duda et al. 2011). 
 
2.5.3	  Tumor	   microenvironmental	   control	   –	   why	   don’t	   we	   all	   get	  
cancer?	  
If one in three people will get cancer, why then will two of three not get cancer? What are 
the underlying mechanisms that protect the majority of us from cancer?  
 
A large number of genes are now known to influence cancer development in a cell 
autonomous fashion. The illegitimate activation or inactivation of oncogenes and tumor 
suppressor genes, respectively, by genetic or epigenetic mechanisms is now a very well 
studied field. There are various ways to protect the integrity of the body against the 
emerging cancer. At least five types of surveillance functions have evolved to counteract 
the probability of cancer development (Klein, Imreh et al. 2007). 
 
 They can be classified as follows: 
-­‐ immunological (mainly directed against virally induced tumors) 
-­‐ genetic (DNA repair, checkpoint functions) 
-­‐ epigenetic (imprinting, chromatin structure) 
-­‐ intracellular (programmed cell death) 
-­‐ intercellular (microenvironmental).  
 
The microenvironmental control is emerging as a major restraining force that can prevent 
the growth of malignant cells (Klein, Imreh et al. 2007; Klein and Demant 2008; Klein 
2009; Allen and Louise Jones 2011; Bissell and Hines 2011). It may be partially or fully 
responsible for Peto’s paradox, the fact that large mammalians do not have more tumors 
than small rodents, in spite of the high degree of conservation of oncogenes, tumor 
suppressor genes and signal transduction pathways that control cell proliferation (Bredberg 
2009; Caulin and Maley 2011). Traditionally, this restraint has been attributed to 
immunological mechanisms. The role of the immune system in tumor development is 
complex, as shown by the many possible infiltrating immune cells in the tumor stroma. Solid 
tumor infiltration by immune cells can be both a good and bad prognostic marker (Zitvogel, 
Kepp et al. 2010). For example, macrophages may promote tumor growth by chronic 
inflammation whereas infiltrating T and NK cells may control cancer development (Pages, 
Galon et al. 2010). However, in many cases the immune system “tolerates” the tumor 
allowing it to survive. The control function of the immune system is evident in 
immunosuppressed individuals, where oncogenic virus infections often leads to tumor 
development, such as Kaposi sarcomas, diffuse large cell B-cell lymphoma, cervical and 
liver cancer (Schulz 2009; Vajdic and van Leeuwen 2009). Post-transplant 
lymphoproliferative disease, a malignant B-cell lymphoma caused by Epstein Barr virus 
(EBV), is an extreme example of an opportunistic tumor, which is only able to take over 
when the patients immune system is severally compromised (Bower 2002). It is clear that 
the immune system is involved in surveillance against tumors, but it is also becoming 
obvious that non-immune controls play a major role in the protection against non-viral 
tumors, regarded as "self" by the immune system. After all, these cancers constitute more 
than 80% of all tumors (Hanahan and Weinberg 2011). 
 
In 1775, Percival Pott found an association between exposure to soot and a high incidence of 
squamous cell carcinoma of the scrotum in London’s chimney sweeps. This was the first 
example of a specific cancer related to a specific occupation, demonstrating that a 
malignancy could be caused by an environmental carcinogen (JAMA 1963). In the early 
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1940’s, Berenblum showed that the weakly carcinogenic croton oil, applied alternately with 
small doses of benzopyrene to mouse skin induced a larger number of tumors than 
benzopyrene would do alone. Subsequently, Moltram found that a single subcarcinogenic 
dose of benzopyrene followed by multiple applications of croton oil could induce a large 
number of skin tumors. These experiments provided the basis for the two stage model of 
carcinogenesis where the initiator (mutagen) agent has to be followed by a non-mutagen 
irritant to induce skin cancer with high likelihood (Slaga 1983). Chemical identification of 
different tumor promoters showed that their main action was to generate unspecific tissue 
damage, local inflammation and reactive hyperplasia in the near vicinity of the mutagenized 
cells. This points in the direction of the potential importance of the altered 
microenvironment in the course of tumorigenesis. Other early evidences, for the capacity 
of normal cells to inhibit cancer cells, came from Stoker in the 1960’s showing that normal 
mouse fibroblasts can inhibit the growth of polyoma virus transformed hamster tumor cells 
(Stoker 1964; Stoker, Shearer et al. 1966) 
 
The revolution in molecular biology, from 1953 and onwards, contributed to a strong focus 
on transformation associated genetic lesions in the tumor cells, as the cause of cancer. The 
role of a potential microenviromental control of tumor growth was not sufficiently 
appreciated, despite the early findings suggesting its important role. The interest in the role 
of normal non-damaged tissue in the control of neoplasia was raised first after it was 
shown that reestablishment of normal tissue architecture can override the malignant 
phenotype. Rous sarcoma virus, carrying the very potent oncogene v-src, could not give rise 
to tumors when introduced into chick embryos but could massively transform the chick 
embryo cells when they were separated in culture. On the other hand, Rous sarcoma virus 
could induce tumors in association with wounds in the chick (Dolberg and Bissell 1984). This 
suggested that the context, the surrounding environment, in which the cells exist, determines 
their fate (Beliveau, Mott et al. 2010; Bissell and Hines 2011). A striking example of this can 
be highlighted by the experiments of Mintz and Illmensee who demonstrated that it was 
possible to normalize malignant mouse teratocarcinoma cells by implantation into early 
mouse embryos (Mintz and Illmensee 1975). Reconstruction of polarity and/or acinar 
structure in epithelial tumors or induction of differentiation in hematopoietic or germ cell 
derived tumors, are other examples that may prevent or reverse malignant growth (Itoh, 
Nelson et al. 2007; Partanen, Nieminen et al. 2007; Partanen, Nieminen et al. 2009). In 
contrast, disruption of the normal tissue equilibrium by inflammation, regeneration or 
wound healing may promote the growth of potentially or frankly neoplastic cells (Beliveau, 
Mott et al. 2010; Erez, Truitt et al. 2010).  
 
 
2.6	   DRUG	  SENSITIVITY	  ASSAYS	  
2.6.1	  How	  can	  we	  find	  the	  best	  drug	  for	  one	  patient	  
Why is cancer in so many cases so difficult to cure? Part of the explanation may be the escape 
of tumor cells from multiple controls illustrated by the accumulation of several changes both 
within the tumor and within the tumor stroma. Moreover, cancer is a personal disease; every 
cancer is different as every person is different from each other. Most of the 200 different 
cancer diagnoses in humans can be further split into numerous prognostic subgroups, based 
on various histological and molecular progression markers (Wright, Tan et al. 2003; Barton 
and Swanton 2011; Schwalbe, Lindsey et al. 2011). 
 
The clinical experience shows that patients, even with the same form of cancer, at a similar 
stage of disease, may respond differently to treatment. The greatest challenge of modern 
cancer therapy is to develop individualized treatment for each cancer patient. 
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Trying to treat most cancers means to expose the patients for heavy drug treatment in 
combination with radiation and surgery. The side effects of the treatment can be devastating 
and are often the major limiting factor of the therapy. In other words, cancer treatment 
involves considerable risks, pain and suffering for the patients (McKnight 2003). Caring for 
cancer patients belongs to the most expensive activities of the healthcare system (Karlsson, 
Nygren et al. 2001). Cancer drug treatment protocols are the result of carefully controlled 
clinical trials involving thousands of patients over many years. During the last decades we 
have seen a striking improvement in patient survival in several forms of human malignancies, 
particularly in leukemias and lymphomas. The development was the most impressive in the 
case of pediatric leukemias (Terracini, Coebergh et al. 2001). For these diseases the careful 
grouping of patients according different biological markers and prognostic indicators proved 
to be crucial for selection of the most effective treatment protocols. These protocols heavily 
rely on the use of relatively old drugs that were developed in the late 1960’s and early 1970’s. 
Key factor to achieve the greatly improved survival was the rigorous adherence to highly 
standardized treatment protocols. This strategy, although very successful in terms of saving 
lives of pediatric patients, resulted in very aggressive treatment with significant toxicity. 
Moreover this strategy left very little room for introduction of novel drugs (Ablett, Doz et al. 
2004). 
 
Today there are more than hundred anticancer drugs approved in the European Union. In 
addition there are several hundred new drugs in clinical trials or in the development pipeline 
of the pharmaceutical industry. It is notable that it is only 68 years ago since a Hodgkin’s 
lymphoma patient was the first cancer patient to be treated with chemotherapy (Hirsch 2006; 
Joensuu 2008). The plethora of different possible effective drugs today leads to a logistically 
very difficult but important challenge: how to find the most suitable drug for any given 
patient (McKnight 2003).  
 
There are different ways to approach individualized therapy in the cancer ward. One way is 
to try to generate an extensive molecular map of the tumor with the expectation that this will 
lead to better understanding of the behavior of the tumor and consequently to more efficient 
therapy. The precise molecular mechanism of many cancer associated regulatory changes has 
been elucidated and led to the treatment of “drugable targets” in cancer (Hsieh and Moasser 
2007; Perrotti and Neviani 2008).  
 
Another way is to use in vitro drug sensitivity assays to determine the sensitivity profile of 
tumor cells. This approach was already introduced forty years ago to analyze leukemic cells 
(Bertelsen, Sondak et al. 1984). A variety of techniques were developed that aimed to 
determine the viability of tumor cells after in vitro culturing with the relevant drugs. Some of 
these techniques are widely used such as the ATP conversion, MTT-reduction or FMCA 
(fluorometric microculture cytotoxicity assay) assays and were proven to be able to provide 
clinically useful information about the drug sensitivity of cancer cells (Larsson and Nygren 
1993; Larsson and Nygren 1993; Nygren, Fridborg et al. 1994; Hayon, Dvilansky et al. 2003; 
Sargent 2003).  
 
The potential of high-content high-throughput microscopy assays in drug discovery has 
previously been demonstrated (Starkuviene and Pepperkok 2007). To use automated high 
throughput imaging to measure the effect of different drugs on cell viability is a commonly 
applied industry scale technique, regularly used by all the major pharmaceutical companies 
for large-scale drug screening projects. Only selected academic institutions or consortia can 
afford to operate these devices in basic research. Furthermore, high throughput imaging 
devices are practically absent from routine clinical laboratories. 
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In this thesis we have developed an automated drug sensitivity microscopy assay (viability 
assay). Using automated fluorescence microscopy and robot printed drug plates we can 
measure drug effects, at the single cell level, of many different drugs in a parallel fashion. 
 





Figure 2.7 Hierarchical clustering of in vitro drug sensitivity data of 77 primary CLL 
samples. The intensity of the red color corresponds to drug sensitivity. Seven-patient 
subgroups were identified on the basis of co-segregating drug-sensitivity patterns and are 
marked with Latin numerals. Figure adapted from (Skribek, Otvos et al. 2010). 
 
 
                      
 
 
Figure 2.8 Illustrating the need for individulized cancer therapy. It may be possible to find 
drugs that are effective to very resistent tumors. Even though the tumor cells from a late 
stage ovarium cancer were found to be resistent for the majority of the drugs tested, two 
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Automated platform 1 (Paper I - IV): 
Confocal + widefield  
Modified UltraVIEW LCI (Perkin Elmer, USA)  
Zeiss Axiovert 200 M, inverted (Zeiss GmBH, Göttingen, Germany) 
CSU10 Yokogawa spinning disc confocal unit (Yokogawa, Japan) 
Motorized XY-table (Märzhauser, Germany) 
ORCA ER cold CCD camera (1344 × 1024 px) (Hammamatsu, Japan) 
Illumination: 
Argon-Krypton Laser; 488 nm, 568 nm, 647 nm (Melles Griot, USA) 
Mercury lamp (Osram); 365 nm  
Mac OS X (processor Dual 2.5 GHz PowerPC G5)  
RAM memory 2GB 
 
Automated platform 2 (Paper VI; Extended field movie): 
Confocal + widefield  
Modified UltraVIEW LCI (Perkin Elmer, USA)  
Zeiss Axiovert 200 M, inverted (Zeiss GmBH, Göttingen, Germany) 
CSU10 Yokogawa spinning disc confocal unit (Yokogawa, Japan) 
Motorized XY-table (Märzhauser, Germany) 
ORCA ER cold CCD camera (1344 × 1024 px) (Hammamatsu, Japan) 
Illumination: 
Solid state laser 491 nm & 561 nm (Cobolt, Sweden) 
Mercury lamp (Osram); 365 nm  
Mac OS X (processor Dual 2.5 GHz PowerPC G5)  
RAM memory 2GB 
 
Automated platform 3 (Paper V - VI): 
Widefield 
Nikon Diaphot 200, inverted (Nikon, Japan) 
Motorized XY-table (Märzhauser, Germany) 
Illumination:  
X-Cite 120 (Lumen dynamics, Canada) 
Retiga-4000RV (2048 x 2048 px) (QImaging, Canada) 
Mac OS X (processor 2 x 3 GHz Quad-Core Intel Xeon) 
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3.1 PAPER	  I	  
Extended	   Field	   Laser	   Confocal	   Microscopy	   (EFLCM):	   Combining	  




In Paper I, we demonstrated that it was possible to create a high-resolution, seamless 
confocal Gigapixel-montage (5,75 mm x 4,98 mm area) by combining automated image 
capture with Nipkow spinning disk confocal microscopy (Figure 8, Paper I). We have 
developed a set of computer programs that controls automated image capture (Quantcapture 
4.0, Figure 1, Paper I) and seamless stitching of large image stacks (the Virtual Microscopy 
program, Figure 2-6, Paper I). We also showed that this method allowed extended field 
imaging, in confocal or wide-field mode at low or high resolution, of full mount embryos 
(Figure 3.1.1) and of transfected cells on culture slides (Figure 3.1.2).  
 
Performing automated confocal fluorescence microscopy over large areas at high 
magnification and high-resolution, imposes several requirements on the capture process. The 
narrow field of view of high magnification objectives requires the capture of many 
consecutive tiles in order to span large xy-dimensions. The reduced depth of field of high-
resolution optics let only a thin layer of the sample to be in focus at one time, which requires 
the capture of several z-planes to ensure that the entire volume of a specimen is included 
(Farkas, Leif et al. 1999; Hammond and Glick 2000). In addition, neither the xy-stage of a 
microscope, microscope slides nor mounted specimens are completely horizontal and no z-
motor works without a z-drift. A major challenge in multi-field captures is therefore to find 
and to keep the object in focus across an extensive stage travel. Different methods of auto-
focusing processes include reflection of reference points or the illumination of the specimen 
to find the optimal focus (Bravo-Zanoguera, Laris et al. 2007). These processes demand extra 
modules, are relative time consuming and most importantly they exhibit the sample for 
additional illumination with potential photobleaching and phototoxic effect, without 
generating any additional information.  
 
Using single-point scanning confocal (SPSC) system the total capture time depends on the 
time needed to scan each focal plane. To reduce the scanning time by increasing the intensity 
of the laser illumination will only work to an upper limit defined by fluorescence saturation. 
Too intense excitation will deplete the electronic ground state of the fluorophore, and instead 
of the desired effect, effectively decrease the fluorescence and increase phototoxicity (Wang, 
Babbey et al. 2005). The collection of multi-field images with individual optical sections will 
also require extensive memory handling capacity and complicated 3D-rendering software for 
volume stitching.   
 
In order to reduce the scanning time and increase the sensitivity of the detector system, we 
chose to use cold CCD camera combined with the Yokogawa spinning disc confocal unit to 
minimize out-of-focus blur. Our aim was to collect all signals through the z-depth of the 
specimen, without rendering a 3D volume.  
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Figure 3.1.1 Extended field microscopy of whole mount embryo, visualizing blood vessels using 
endothelial CD31 antibody-staining (staining by Renhai Cao, with kind permission to reprint) 10 x 8 
fields, 10X; (835 x 636 um/field). Raw images (left), after flat-fielding and pixel precise alignment 




       
 
Figure 3.1.2 LANA-1 expression does not affect 3MK9H3 (green) levels as measured using 
extended field laser confocal microscopy (EFLCM), 300 (20 x 15) adjacent fields (as illustrated by 
the mosaic image and zoom-in at individual nuclei image). The total fluorescence intensity 
measurement for 3MK9H3, DNA (blue) and LANA-1 (red) of individual nuclei, is plotted in the 
order of increasing amount of LANA-1 (Y-axis: fluorescence intensity, X-axis: number of cells). 
The amount of 3MK9H3 staining is also compared on population levels of LANA-1 positive and 
negative nuclei on a box chart. Reprint from (Stuber, Mattsson et al. 2007). 
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The Quantcapture 4.0 program was developed using the visual programming language 
Openlab Automator. The visual programming environment allowed us to design flow-charts 
of icons linked together to control each step of the image capture process. In addition to the 
hardware control, the language also maintains image processing and measurements tools 
supporting the declaration of string, numeric and array variables (bird-eye view of the 
flowchart, illustrating the concept, can be found in Figure 1, Paper 1 and under 
Methodological considerations, Figure 6.2.3 A). 
 
In Quantcapture 4.0, the first command prompts the user to define the extent of the capture 
area, by fixed numbers of images in the xy-direction or by a manual selection of xy-
coordinates. The user defines the z-values for the highest and lowest focal planes, at each 
corner of the capture area. The z-depth is calculated as the difference between the extremes 
of the 8 different z-values, ensuring that the sample will be in focus during the extended field 
capture. 
 
CCD cameras convert incoming photons into electrons that are stored in wells of a camera 
chip. A pixel-well value is read out as a voltage, which after amplification, passes through an 
analog to digital converter and forms an image of digital pixel values. Digital fluorescence 
images are always corrupted by different sources of noise (dark current, pixel non-uniformity, 
shot noise, etc.) that are introduced during the integration and read out of an image from a 
CCD. One problem with projecting an image stack is that noise from all of the optical 
sections is incorporated into the projection. This effect is particularly severe with sum 
intensity projections, where all value of each image is included, regardless if it is a true signal 
or noise. Capturing images at very low light level will increase the risk that also random pixel 
noise will be included in the final image even when using max intensity projection 
(Hammond and Glick 2000). This effect can be attenuated by use of median filtering. 
  
Instead of capture single z-layers, we developed the Moving Z-capture process. This process 
let the sample move from top to bottom focus along the z-axis, while the cold CCD-
camera collects all signals during one total exposure, without closing shutter in between the 
z-steps. Using the Moving Z-capture, only one image consisting of all signals along the 
entire z-axis is produced. The Nipkow spinning disc technique assures that only light with 
minimal out-of-focus blur reach the detector, from every focus plane. The z-travel was 
performed step-wise in both Moving Z-capture and in the conventional capture process. 
The exposure time at each step through the z-stack was identical between the two types of 
capture techniques. The difference was that in the Moving Z-capture the camera also 
collected signals even in between the steps, making the exposure time through the part of 
the z-depth that actually displayed the sample relatively longer compared to a single layer 
capture. Moreover, a sum-projection of individually captured z-layers multiplies the 
background camera noise by the number of z-layers. As we have measured, the background 
cold CCD camera noise contributes only once to the final image generated by the Moving-
Z capture. This background was also removed using the total exposure "dark background" 
image (more technical details on the Moving Z-capture loop can be found under 
Methodological considerations, Chapter 6.2) 
 
Images captured by the Moving Z-capture technique had better quality than images captured 
by a conventional confocal capture process (sequential capturing of z-planes). We compared 
images acquired using the Moving Z-capture (Figure 3.1.3 A) with 20 images taken from the 
identical z-depth but in a sequential fashion (Figure 3.1.3 C & 3.1.3 D). Figure 3.1.3 C & 3.1.3 
D show the sum and maximum projections, respectively, of the 20 images-stack. Figure 3.1.3 
B shows the quality of one single z-layer from the 20-images stack.  
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Comparison of the gray levels histogram for the different images show that the gray levels 
were more spread when the Moving Z-capture was performed, suggesting better contrast 
(Ramirez, Ozawa et al. 2011).  
 
 
           
 
Figure 3.1.3 Moving Z-capture (A) versus single layer capture of 20 z-layers (B-D), z-layer in a stack 
of 20 images (B) sum-projections of 20 z-layers (C) max-projections of 20 z-layers (D). 
  
 
In order to perform pixel precise alignment of 3000 confocal images into a seamless mosaic, 
every image was taken with a fixed overlap (Figure 4, Paper I). We introduced a new software 
for image processing; the ImageLab/Virtual Microscope program. Using this program, we 
could perform image processing and compensate for optical and mechanical imperfections, 
inherent in the automated image capture processes (due to motorized xy-step limitations, 
uneven illumination and misaligned camera) (Figure 5-6, Paper I). This software permitted 
image processing of large image data sets on ordinary desktop computers, commonly used in 
the academic environment, and allowed virtual microscopy visualization (Figure 2-3, Paper I). 
 
Through this publication, we would like to advocate that visual programming languages 
enable users to make complicated but flexible image capture applications for automated 
microscopy, without broad knowledge of complex computer languages. The automated 
capture process allows image capture without a human bias in the selection (after initial 
settings) and it assures identical exposure times for all images. In summary, this technique 
allows quantitative measurements of (even weak) fluorescence signals and morphological 
parameters on a large number of cells or on entire histological sections.  
 
The presented method, in combination with quantification programs developed by us in 
Openlab automator (QuantCount 3.0 and CytotoxCuant 3.0) was applied in different 
biological studies, such as imaging and quantification of epigenetic effects of transformation 
associated viral nuclear antigens, as shown in Figure 3.1.2 (Stuber, Mattsson et al. 2007) and 
quantification and analysis of labelled tumor cells in 384-well plates (Markasz, Kis et al. 2007; 
Markasz, Skribek et al. 2008; Markasz, Vanherberghen et al. 2008). 
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3.2 PAPER	  II	  
Multi-­dimensional	   laser	   confocal	   microscopy	   on	   live	   cells	   in	  
submicroliter	  volumes	  using	  glass	  capillaries	  
	  
 
With the advancement of different cell separation techniques (multicolour preparative flow 
cytometry, combined positive and negative magnetic separation, direct micromanipulation of 
living cells etc.) there is an increasing need to study isolated rare cells in various biological 
context such as cell-cell communication and target-effector interactions, and to do this in 
limited volumes. In Paper II, we have developed a technology that permits live cell imaging 
of a very small number of cells at the maximal resolution of the light microscope, in multiple 
dimensions over time (Figure 7, Paper II).   
 
In our experience, when incubating cells in a rich (high amino acid, high pyruvate) HEPES 
buffered medium with free radical scavenger selenium (Iscoves modified Dulbeccos medium) 
the cells were stable and performed normal functions unhindered when observed for many 
hours - days, in closed POCmini chambers, in 400-600 µl incubation volumes (Perfusion-
Open-Closed-system) (Figure 2.3). These observations prompted us to test much lower 
incubation volumes, for closed chamber live cell imaging. 
 
We hypothesized that the round geometry of the thin walls of polymerase chain reaction 
(PCR) capillaries, at high magnification could be regarded as a sufficiently flat surface as not 
to distort the quality of microscopy images.  
 
We demonstrated that living cells could be imaged in submicroliter volumes in glass 
capillaries using Nipkow disc based confocal microscopy (Figure 2-6, Paper II). We reasoned 
that using immersion oil with the same refractory index as the glass wall of the capillary the 
geometry of the wall does not necessarily have to be plane parallel. We tested two types of 
glass capillary set ups, one with 2-4 µl volumes and one with submicroliter incubation 
volumes. In both cases we used 10 µl glass capillaries designed for capillary PCR. These 
capillaries are particularly amenable for creating optically homogeneous thin capillaries upon 
heating and constant power pulling. The capillaries were loaded with cell suspensions using 
surface tension as the only source of power. A small drop of cells in culture medium, put on 
the hydrophobic surface of parafilm, could be fully loaded simply by touching it with the 
orifice of the capillary. Sealing both ends of the capillary created a closed and well-controlled 
environment that could support the life of the encased cells for hours. We found that this 
simple set-up gave comparable results to those complex, very expensive and cumbersome 
environmental chambers (with controlled CO2, humidity and temperature) that are routinely 
recommended for live cell imaging experiments (Stephens and Allan 2003). The only 
technical requirement of our set-up is an objective heater that maintains the correct 
temperature of the immersion oil drop. Our set-up permits the adaptation of complex live 
cell experiments in any laboratory that posses an inverted fluorescence microscope with 
CCD camera and an objective heater. Additionally, a spinning disc system allow fast, 
confocal multidimensional imaging of the sample, with a low rate of photobleaching (Wang, 
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3.3 PAPER	  III	  
Cytotoxic	   drug	   sensitivity	   of	   Epstein-­Barr	   virus	   transformed	  




Treating patients with Epstein Barr virus (EBV) induced B-cell lymphoma is a challenge. 
Patients who succumb to this disease are immunocompromised, a risk group that is already 
extra vulnerable for cytostatic drug treatment and its heavy side effects. Yet, this is in severe 
cases where the lymphoma is resistant to Rituximab (anti-CD 20 mAb) a necessary choice of 
treatment. Trying to find the most effective drug or drugs that would kill EBV-immortalized 
B-cells, at low concentrations, to minimize side effects, was the aim of this study.  
 
EBV is one of the most common viruses in the human population. Normally the infection 
occurs asymptomatically during childhood, while primary infection in adults leads to 
infectious mononucleosis in half of the cases (Lewin, Aman et al. 1987). Up to 90% of the 
adult population carries the virus, as a latent infection throughout life (Fields, Knipe et al. 
1996; Kieff and Rickinson 2007). Latently infected B-lymphocytes are kept in check by 
cytotoxic T-lymphocytes, which exert a strong specific immunity (Rickinson, Lee et al. 
1996; Gustafsson, Levitsky et al. 2000). When the immune system is suppressed, as it is in 
AIDS patients or due to medication in patients after organ transplantation, EBV may 
become lethal. Two forms of acquired immunodeficiency have dominated the last quarter 
of the twentieth century and are responsible for the majority of lymphomas in the 
immunosuppressed: post-transplantation lymphoproliferative disorders (PTLD) and AIDS-
related lymphomas (ARL) (Bower 2002). The reported overall mortality for PTLD often 
exceeds 50% (Opelz and Dohler 2004). The prognosis for PTLDs occurring after bone 
marrow transplantation is even worse (Orazi, Hromas et al. 1997). EBV infects the B-cell, 
hijacks its genetic machinery and encodes transformation-associated proteins that drive the 
B-cells into massive proliferation, both in vivo and in vitro. The in vitro generated 
lymphoblastoid B-cell lines (LCL) show very similar properties to the in vivo disease and are 
therefore a good model for studying the clinical syndrome (Rowe, Young et al. 1991). 
 
Using our automated fluorescence microscopy system 1, in combination with a fluid 
dispenser robot for drug printing, we have developed an assay for high throughput drug 
sensitivity testing. We have in Paper III studied the effect of 29 different drugs on 17 
different lymphoblastic cell lines.  
 
Summarizing the drug effect of all 17 LCLs and plotting the mean cell survival for each drug 
allowed us to identify potent cytostatic drugs against LCLs. We found four drugs that were 
highly effective, even at lower concentration than would be normally used in the clinic: 
vincristine, paclitaxel, methotrexate and epirubicin (Figure 4, Paper III). 
 
Vincristine and methotrexate are already included in the treatment of PTLD. Epirubicin and 
paclitaxel on the other hand were not found in protocols for EBV induced 
lymphoproliferative diseases. Our data suggests that these two drugs, which are already 
accepted for use with well-known efficacy on other tumors, might be possible alternative 
treatments for PTLD. 
 
The drug sensitivity assay was designed as a three-day long co-culture of cells and drugs in 
384-well plates. The result was based on fluorescence showing the viability of single cells 
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after treatment, in comparison to untreated cells. Each drug was tested at four different 
concentrations, in triplicates, in a total pattern of 12 wells per drug (Figure 3.3.1). It is 
possible to measure the concentration dependent effect of 30 different drugs in one plate. 
The drug plates were produced using a fluid-handling robot. The dilution series and loading 
of a drug master-plate was fully automated. The master-plate then served as a template to 
mass-produce replica plates using metal pin printing technology. 
 
 
Figure 3.3.1 Drug dilution schedule in a 384-well plate. Each drug is tested in 4 concentrations and in 
triplicates (A). Concentration dependent drug effect: most cells are dead in the highest concentration 
of the drug (bottom panel) while most cells are alive in lowest drug concentration (top panel) (B). Live 
(yellow)/dead (blue) cell discrimination (C). Figure adapted from (Otvos, Skribek et al. 2011). 
 
After three days of co-culture, a fluorescence dye mixture that discriminate between live and 
dead cells (VitalDye) was added to the cells.  Two images per well (768 images per plate) were 
captured using the automated microscope platform 1. The extended field program 
QuantCapture 4.0, described in Paper I, was adjusted to fit for 384-well capture. The z-depth 
was calculated as the difference between the focuses in the four corner-wells and the Moving 
Z-capture loop was applied to ensure that all signals from cells at different z-levels were 
recorded during the xy-travel across the plate. Images were captured using low magnification 
(3.5 X) objective, allowing visualization of almost the entire well in one image. The Moving 
Z-capture proved useful, despite the non-optimized confocal settings at 3.5X. In our 
experience the laser excitation through the Yokogawa head (the Nipkow spinning disc 
confocal unit) gave better image quality than normal wide-field mercury lamp excitation.  
 
Automatic quantification of all cells was performed using the program QuantCount 3.0, also 
developed by us in the visual programming environment Openlab Automator. Combining 
several image processing concepts into a single complex flowcharts made it possible to 
identify and count individual cells (bird-eye view of the flowchart, illustrating the concept, 
can be found under Methodological considerations, Figure 6.2.3 B) In essence, the 
background noise was calculated from four empty wells using a smoothing filter and was 
subtracted from the image stack. The smoothed background image was also used to map the 
illumination inhomogeneity across the area of the well. Using this pattern, a series of 
correction values were calculated corresponding to defined areas of ring shaped segments of 
isoluminescent fields. These values were used to multiply all the other images using the areas 
of the ring segments as binary masks. This procedure compensated for the inherent loss of 
fluorescence at the periphery of the wells.  
  27 
A sharpening filter was applied to enhance the contours of the cells. An optional quality 
check for binary thresholding was also implemented that allowed direct visual interpretation 
of any selected image. This method permitted an easy adaptation of automated image 
quantitation for plates of variable background and fluorescence intensity. Objects were 
defined as pixel clusters over a defined cut-off intensity value and were represented by a 
binary mask. Quantification was done on objects larger than a pre-set pixel number matching 
the actual cell size, to exclude debris. The final analysis of cell numbers was performed in 
Excel. We developed sheets, linked in several layers in order to automatically calculate the 
number of living and dead cells. In Paper III, the data is presented as the mean cell survival 
of 17 LCLs together with standard deviation, marked with grey shadow (Figure 1-2, Paper 
III).  
 
EBV transformed B-cells show little genetic heterogeneity due to the fact that the virus 
encoded latency associated proteins are solely responsible for the transformation. This fact 
was revealed in the uniform pattern of drug sensitivity among the lines tested. This uniform 
response in the measurements also served as a demonstration of the robustness and 
reproducibility of the assay. 
 
The presented work pioneered our studies on drug sensitivity testing which we have carried 
out using the automated microscopy systems, over the last five years. The long-term goal 
with the presented method is to develop a high throughput optical assay for routine clinical 
use to determine the cytotoxic drug sensitivity of human tumor cells against all available 
licensed and experimental drugs. 
 
 
3.4 PAPER	  IV	  
Effect	   of	   frequently	   used	   chemotherapeutic	   drugs	   on	   cytotoxic	  
activity	   of	   human	  natural	   killer	   cells	   -­	  Drug	   sensitivity	   test	   using	  
automated	  microscopy	  and	  differential	  imaging	  
 
 
The aim of this study was to determine whether cytostatic drugs could interfere with natural 
killer (NK) cells mediated cytotoxicity.  
 
NK cells are part of the innate immune system and they can have direct cytotoxic effect 
against tumor -and virus-infected cells (Cerwenka and Lanier 2001) (Figure 1, Paper IV). 
Elevated infiltration of NK cells into solid tumors is associated with better clinical prognosis 
(Coca, Perez-Piqueras et al. 1997; Ishigami, Natsugoe et al. 2000). For this reason they have 
become of great interest for the treatment of cancer. In immune-based adjuvant therapy 
settings, NK cells are administered in order to target malignant cells, with the hope of a 
better clinical outcome for the patient (Ruggeri, Mancusi et al. 2006). Drug sensitivity profiles 
of NK cell activity would be valuable information in NK cell based immunotherapy 
protocols. Previous studies have only assessed a few drugs for their effect on NK-
cytotoxicity (Utsugi, Demuth et al. 1989; Ujhazy and Babusikova 1991). 
 
In Paper IV, we measured the efficacy of NK cell mediated cytotoxicity after treatment of 29 
different drugs, which are routinely used in the clinic to treat cancer patients. Our data 
implied that chemotherapy protocols including proteosome inhibitors (such as bortezomib) 
or anti-microtubule drugs (paclitaxel, docetaxel and vinblastine) may interfere with NK cell-
based immunotherapy, if applied simultaneously (Figure 4A, Paper IV). It is well-known that 
microtubule-disrupting agents prevent the NK-mediated killing of target cells (Katz, Zaytoun 
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et al. 1982). On the other hand, we found drugs that had almost no inhibitory effect on NK 
cell-mediated killing, even at high concentrations. We therefore suggest that these: 
asparaginase, bevacizumab, bleomycin, doxorubicin, epirubicin, etoposide, 5-fluorouracil, 
hydroxyurea, streptozocin, and 6-mercaptopurine and could effectively be combined with 
adjuvant NK cell-based immunotherapy (Figure 4C, Paper IV).  
 
The importance of cytostatic drug effects on NK cell activity is further underscored by our 
subsequent finding that efficient Rituximab treatment of EBV transformed B-cells requires 
preserved NK cell activity. We conclude that it is important to consider the choice of 
cytostatic drug treatment when it is administered in combination with monoclonal antibody 
therapy (Markasz, Vanherberghen et al. 2008). 
 
In this study eight primary NK cell isolates were tested, all derived from healthy donor blood. 
The target tumor cell line was K562, a non-adherent, immortalized myelogenous leukemia 
cells line, known for its sensitiveness for NK cell killing activity (Lozzio and Lozzio 1979). 
NK cell isolates were treated with 29 different drugs, in four concentrations and in triplicates, 
in a 384-well plate set-up identical to the drug sensitivity assay described in Paper III. Instead 
of three days, NK cells were only co-incubated with the cytostatic drugs for 20 hours. K562-
cells were labelled with a green fluorescent dye (compatible with living cells) and 
subsequently co-incubated with the drug-treated NK cells for 5 hours, in an effector-to-target 
ratio 6:1. We found that a 5-hour co-incubation was long enough to record NK cell mediated 
killing, which usually happens within the first hour (Figure 1, Paper IV). At the end of the 
incubation time, ethidium bromide was added to all wells, to selectively stain dead cells red. 
The automated microscope platform 1 and the QuantCapture 4.0 program, described in 
Paper I & Paper III were used to automatically capture images of all wells in the 384-well 
plate. The QuantCount 3.0 program (described in Paper III) was used to automatically 
quantify green (K562) and red (dead K562 and NK) cells. In this study the number of dead 
target cells defined the measure of NK cell killing efficacy, after drug treatment. Dead target 
cells were defined as the green labelled K562 cells that also were stained red. NK cells in 
culture can go through spontaneous apoptosis. This has to be taken into account when 
performing the dead cell quantification, since dead NK cells would also be stained red by the 
ethidium bromide. In order to only quantify dead target cells, we developed the 
CytotoxCount 3.0 image analysis program (bird-eye view of the flowchart, illustrating the 
concept, can be found under Methodological considerations, Figure 6.2.3 C). Using the visual 
programming environment in Openlab Automator we designed a program dedicated to the 
analysis of differential labelling of the same cells, in a mixed cell culture. We used “Boolean 
AND” based image comparison for the final readout of dead target (red and green double 
positive) cells.  
 	  
3.5 PAPER	  V	  
High-­throughput	  live-­cell	  imaging	  reveals	  differential	  inhibition	  of	  
tumor	  cell	  proliferation	  by	  human	  fibroblasts	  
	  
 
The tumor microenvironment plays a significant role in cancer development (Tlsty and 
Coussens 2006; Li, Fan et al. 2007; Goetz, Minguet et al. 2011). It is now well known that the 
activated stroma, with recruited inflammatory cells and CAFs can promote tumor 
development (Ostman and Augsten 2009; Erez, Truitt et al. 2010). It is less well known what 
role the normal stroma has in the early stages of cancer. A growing body of evidence point 
toward a microenvironmental control function of the intact stroma, in regulating the 
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behavior of neoplastic cells (Dolberg and Bissell 1984; Glick and Yuspa 2005; Partanen, 
Nieminen et al. 2009; Beliveau, Mott et al. 2010). Whether there is any cancer relevant 
genetic variation in microenvironmental control of tumor development has not been 
studied at all. The mechanism of tumor microenvironmental control is only partly known, 
with all members of the ECM as potential effectors. Among its known effectors, fibroblasts 
occupy an important place. The ability of fibroblasts to inhibit tumor cell growth by direct 
contact, originally discovered by Michael Stoker in the 1960s, was our departure point in the 
work in Paper V (Stoker 1964; Stoker, Shearer et al. 1966).  
 
The aim of Paper V was to compare the postulated inhibitory effect of a large panel of 
human primary fibroblasts (107 samples) on tumor cell proliferation. The primary fibroblasts 
were derived from skin of pediatric and adult donors and from hernia, nasal polyps and 
prostate (called internal) biopsies or surgical rest material from adult and pediatric donors.  
 
Six tumor cell lines were included in the study: three prostate carcinoma lines LnCaP (lymph 
node metastasis), PC-3 (bone metastasis) and DU-145 (brain metastasis); two lung cancer 
lines, H1299 and A549; and one Epstein Barr virus (EBV) transformed lymphoblastoid cell 
line, IB4. The tumor cell lines were genetically modified to stably express EGFP or mRFP 
fluorescent proteins; cytoplasmic expression of EGFP (LnCap) or nuclear histone H2A 
expression of mRFP (PC3, DU145, H1299, A549 and IB4). The genetic labeling of tumor 
cells made it possible to follow the proliferation of single cells over time, without losing 
signal due to division (Figure 3.5.1).  
 
             
 
Figure 3.5.1. Illustration of the co-culture set-up: PC3mRFP tumor cells (red) growing on top of a 
confluent monolayer of pediatric hernia fibroblasts (phase contrast). Two time-points: day 0 (A) 
and day 3 (B). 
 
The effect was investigated in a four-day long co-culture set-up, where color-labelled tumor 
cells were seeded on top of unlabelled fibroblasts. Fibroblasts from different donors were 
seeded into separate wells in a 384-well plate and were left for two days to form a confluent 
monolayer, before adding the tumor cells. The proliferation of tumor cells was recorded by 
images taken the same day as seeding (day 0) and after 4 days of co-culture with fibroblasts 
(day 4). Quantification at single cell level, of every tumor cell in all wells at each time-point, 
gave us the day 4/day 0 proliferation ratio for tumor cells growing on different fibroblast 
monolayers and in control wells (labelled tumor cells alone or labelled tumor cells together 
with unlabelled tumor cells). Fibroblasts were divided into subgroups dependent on their 
origin: adult skin, adult internal, pediatric skin and pediatric internal and were regarded as 
inhibitory if they, as a group inhibited tumor cell proliferation (Figure 3, Paper V).  
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We found that primary human fibroblasts differed in their capacity of inhibiting human 
tumor cell proliferation in vitro. The inhibitory effect depended on target tumor cell line, the 
donor age and the fibroblast site of origin. The majority of the fibroblasts could inhibit 
tumor cell proliferation (Figure 4, Paper V). The sensitivity to the inhibitory effect of 
fibroblasts differed between the six tumor lines. Four of six tumor cell lines (LnCap, DU-
145, IB4 and H12999) were highly sensitive for fibroblast-mediated inhibition as 
demonstrated by the inhibitory effect of all fibroblasts as one group compared to the 
control (with a significant p-value <0,05) (Figure 3, Paper V). 
 
Skin fibroblasts, of both adult and pediatric origin, were more effective in their inhibition of 
tumor cell proliferation than fibroblasts derived from internal sites (hernia, nasal polyp and 
prostate). Five of six tumor cell lines (LnCap, DU-145, IB4 and H12999 and PC3) were 
inhibited by all skin fibroblasts (as one group), with a significant p-value <0,05 (Figure 3, 
Paper V). 
 
Sorting individual fibroblasts, according to their summarized inhibitory effect against all 
carcinoma lines, identified fibroblasts with consistently high and with consistently low 
inhibitory capacity. 9 of the 14 most inhibiting skin fibroblasts were derived from children. 
In the least inhibiting group, the majority of the fibroblasts were derived from internal sites 
and 11 of these 15 internal fibroblasts were derived from the prostate of adult donors 
(Figure 5 and 6, Paper V). All prostate biopsies were derived from prostatic cancer patients. 
There is a possibility that these samples could be cancer-associated fibroblasts. Conditioned 
media did not have any inhibitory effect on tumor cell proliferation, suggesting that the effect 
is contact mediated. 
 
In addition, we could confirm the previously reported differential inhibition of SV40-
transformed mouse 3T3 cells by isogenic non-transformed 3T3E and 3T3M fibroblasts, 
that had been characterized as strong and week inhibitors, respectively (Figure 1, Paper V) 
(Allard, Stoker et al. 2003). We also found that the inhibitory effect of the 3T3 fibroblasts 
works across species barrier. Both the 3T3E and the 3T3M lines inhibited the proliferation 
all carcinoma cell lines (Figure 4, Paper V). 
 
Using a 384-well plate, it was possible to analyze 12 different fibroblast samples against a 
panel of six tumor lines, in quadruplets, in one screening event. Fluorescently labeled 
tumor cells were co-cultured with fibroblasts and with unlabeled tumor cells as controls. 
Green (GFP labelled tumor cells) or red (mRFP labelled tumor cells) fluorescence images of 
all wells in the 384-well plate, were captured using automated fluorescence microscopy. 
Bright field images were captured to also register the unlabelled fibroblasts. The 
Quantcapture 4.0 program, developed in Paper 1 for automated extended field confocal 
microscopy, was modified for 384-well plate capture on a wide-field microscopy system 
(Platefocus 10 program, Microscope platform 3). Images were captured using low 
magnification (2.5 X) objective, allowing visualization of the entire well in one image. The 
depth of field (the range of the sample in focus along the optical axis) was relatively long 
(around 20 µm) when using the 2.5X objective, often permitting acceptable focus control of 
across the 384-well plate (of the adherent cells on the bottom of the well), even without 
additional autofocusing. In the case of tilted plates, a brute autofocusing loop was 
implemented to find the best focus depth along a fixed number of z-steps. The stack of 384 
images from each plate, mRFP labelled tumor nuclei or GFP labelled tumor cytoplasm, were 
quantified using image analysis tools in ImageJ.  
 
We have found that performing background subtraction (rolling ball) followed by median 
filtering (3x3) in combination with the find maxima tool, was an effective way to 
automatically quantify tumor cells on single cell level (Figure 3.5.2 A-C). At low magnification 
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(2.5X), the mRFP-labelled nuclei appeared almost as point-like objects, suitable for find 
maxima identification. The stack of hundreds of images was automatically quantified by 
running the find FindStackMaxima macro in ImageJ. To quantify tumor cells labeled by 
cytoplasmic GFP, more considerations were needed. Background subtraction and median 
filtering was followed by a binary threshold and watershed segmentation, in order to 
separate adjacent cells from each other. When analyzing and quantifying the segmented 
cells, small debris could be excluded from the count by excluding particles smaller than a 
fixed number of pixels. This number was set to be significantly smaller than the average 
smallest cell. Quantification was performed using the Analyse particles plugin in ImageJ 





Figure 3.5.2 Image processing for automatic quantification of tumor cells. mRFP-H2A labeled 
tumor cells (2.5X): background subtraction (A), median filtering (B), find maxima identification of 
tumor cell nuclei (C). EGFP-LnCap labelled tumor cells (16X): background subtraction and median 
filtering (D), binary thresholding (E), watershed segmentation (F). 
 
 
In conclusion, we have shown that the co-culture of tumor cells with primary fibroblasts, 
might lead to either growth stimulation or growth inhibition of tumor cells. Fibroblasts 
derived from the prostate of patients diagnosed with prostate carcinoma (potential CAFs) 
were the least inhibiting and occasionally even promoting tumor proliferation. Fibroblasts 
derived from the skin of pediatric patients, were highly represented in the group of the most 
inhibitory fibroblasts. 
 
Our high-throughput study, with over five hundred heterotypic cell combinations, with 
four independent measurements for each sample and individual counting of each tumor 
cell, indicates that the effect of fibroblasts on tumor cell proliferation is predominantly 
inhibitory. The technique allowed us to identify fibroblasts with consistently high and with 
consistently low inhibitory capacity. These findings are valuable to use in further studies 
trying to understand the mechanisms behind inhibition and its possible clinical relevance. 
Our data may reflect part of the fibroblast mediated microenviromental control of tumor 
cell growth.  
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Whether our in vitro neighbour suppression results would correlate with cancer proneness 
of the donors remains to be established. However if such correlations would exist, our 
assay might provide an easy and highly scalable tool to test the inhibitory activity on 
population levels. The assay may also permit the dissection of the mechanism of inhibition 
by high throughput tools where large number of agents (drugs, siRNA, antibodies) can be 
tested for enhancing or abolishing the inhibitory effects of the fibroblasts.  
 	  
3.6 PAPER	  VI	  
The	   differential	   inhibition	   of	   tumor	   cells	   by	   normal	   and	   cancer-­
derived	   fibroblasts	   is	   dependent	   on	   the	   architecture	   of	   the	  
fibroblast	  monolayer	  fibroblasts	  
 
 
As a first attempt to dissect the mechanism of contact mediated inhibition, the aim of Paper 
VI was to investigate the role of the architecture of the fibroblast monolayer. 
 
In the previous study (Paper V), we demonstrated that monolayers of a panel of hundred 
primary fibroblasts could differentially inhibit tumor cell proliferation in vitro. In the course 
of 500 co-culture experiments, we observed a clear difference in the growth pattern of the 
tumor cells growing on top of fibroblasts with different inhibitory capacity. In the inhibited 
cultures, the tumor cells grew in small confined islands (Figure 3.6.1 A-B and Figure 1A, 
Paper VI). Tumor cells growing on non-inhibitory fibroblasts grew in bigger islands and 




Figure 3.6.1  Bird-eye view of fibroblast monolayers in a 384-well plate + zoom in on single wells: 
mRFP-labelled PC3 tumor cells growing on top of fibroblast monolayers with different inhibitory 
capacity. Growth pattern of tumor cells, after 4-days co-culture, on top of two inhibitory 
fibroblasts; Normal patient 1 skin (A) and BjhTERT (B) and on top of two non-inhibitory 
fibroblasts; Cancer patient 2 prostate (C) and Normal patient 1 hernia (D).  
 
A morphological difference between inhibitory and non-inhibitory fibroblasts could also be 
observed when fibroblasts were cultured alone. The inhibitory fibroblasts appeared to grow 
in an organized “whirly” pattern, while non-inhibitory fibroblasts tended to arrange 
themselves in a “crossy” pattern. Our co-culture data suggested that the growth pattern of 
the tumor cells reflected the architecture of the underlying fibroblasts.  
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We selected, for further investigation, four fibroblasts that were identified as inhibiting and 
less-inhibiting in Figure 5, Paper V. One of the least inhibiting prostate fibroblasts “Ö15p2 
AdInt” (Cancer patient 2 prostate) and one of the most inhibiting pediatric skin fibroblasts 
“D6MKsk PedSk” (Normal patient 1 skin) were selected from Figure 6, Paper V. “D6MKin 
PedInt” (Normal Patient 1 hernia) fibroblasts were selected from the less inhibiting 
fibroblasts in Figure 5, Paper V. In addition, telomerase immortalized BjhTERT fibroblasts 
were also selected as a stable inhibitor (Figure 5, Paper V).  
 
We showed that the differences in the inhibitory capacity of normal skin derived 
fibroblasts, as contrasted to non-inhibitory prostate and hernia derived fibroblasts, are 
reproducible and did not depend on the initial number of tumor cells seeded (range 50–800 
tumor cells) (Figure 2A, Paper VI). The inhibitory effect was also shown to be independent 
of the fibroblast passage number (passages 7, 8 and 14) (Figure 2B, Paper VI). 
 
Choosing BjhTERT/mRFP-PC3 as a stable model system, we measured the inhibitory effect 
of different ages of monolayer. We showed that the inhibitory capacity increased significantly 
between two and four days old monolayer suggesting that certain components of the 
monolayer needed to mature in order to exert a strong inhibitory effect (Figure 5A-C, Paper 
VI). Again we confirmed that the inhibitory effect could not be explained solely by soluble 
factors. Supernatant from 8, 6, 4 and 2 days old fibroblasts cultures had no effect on the 
proliferation of tumor cells, independent on the origin of the supernatant. Careful 
examination of the microscopy image in Figure 5D, Paper VI revealed that fibroblasts mixed 
with tumor cells in the “0 days” old monolayer had no effect on tumor cell proliferation nor 
on the tumor growth pattern, i.e. the tumor cells grew in patterns identical to the controls. In 
Figure 6 Paper VI, we also observed that interference with monolayer formation impaired 
inhibition. These data clearly showed that it was not sufficient to have the inhibitory 
fibroblast present in the mixed cell culture, but that they also had to form a confluent and 
sufficiently matured intact monolayer to exert the inhibitory effect.  Our data suggested that 
structured accumulation and deposition of extracellular matrix molecules might provide 
orientation dependent behavioral cues to the tumor cells in an unmanipulated, inhibitory 
monolayer.  
 
We used time-lapse imaging combined with extended field capture (as described in Paper 1, 
and Paper VI modified for the Microscope platform 2) to investigate the continuous 
behavior of tumor cells growing on fibroblast monolayers. We recorded a movie during 
62.5 hours with 49 (7x7) images covering a total area of 4.2 mm x 5.2 mm (22 mm2), 
captured every 15 minutes. A BjhTERT fibroblast monolayer, with strong inhibitory effect 
on tumor cell proliferation (Figure 5 & Figure 7A, Paper VI), was found to reduce the 
motility of the tumor cells during the 62.5 hours long movie (Figure 7B, Paper VI). The 
monolayer from hernia fibroblasts (normal patient 1) on the other hand, had no effect on 
tumor cell motility (Figure 7B, Paper VI) and allowed continuous tumor cell proliferation 
throughout the time of filming (Figure 7A, Paper VI). The finding that growth inhibition 
was associated with loss of motility along the surface of the inhibitory monolayer but not 
on a non-inhibitory monolayer indicated the occurrence of adhesive interactions in the 
former case that could impose cellular polarity. Non-inhibitory cultures might lack the cell 
surface molecules or the ECM components needed for adhesive interactions, permitting 
the continuous rolling of tumor cells over the monolayer and preventing the induction of 
eventual polarity. 
 
RNA-profiling of two isogenic pairs of fibroblasts; the whirly and crossy subclones of the 
TERT immortalized line (BjhTERT) and skin (inhibitory) and hernia (non-inhibitory) 
fibroblasts derived from the same patient (Normal patient 1), identified a set of genes that 
co-segregated with the inhibitory phenotype. This suggests that our model system may 
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reveal molecular mechanisms involved in contact-mediated microenvironmental 
surveillance that may protect the organism from the outgrowth of disseminated tumor 
cells. We are now aiming at the characterization of the behavior of some of these candidate 
molecules in order to gain further insights into the molecular mechanisms of fibroblast 
monolayer induced tumor growth inhibition.  
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5.	   CONCLUDING	  REMARKS	  AND	  FUTURE	  PERSPECTIVES	  	  
 
 
The ambition of this thesis was to develop and implement automated microscopy methods 
into tumor biology research that can potentially be of clinical use. We have developed a set of 
computer programs that were able to carry out automated image capture on different types 
of motorized fluorescence microscopes. In addition, we have designed image analysis 
routines in order to automatically process and quantitate raw image data. Using a flexible 
programming environment, we have applied the acquisition and analysis routines for several 
different experimental settings, in order to answer different biological questions. By 
combining image acquisition and image analysis steps in the same algorithm, we could 
approach intelligent microscope applications where the system can decide how to proceed 
with the image acquisition depending on what the microscope “sees”. 
 
We have demonstrated that using our automated microscopy methods it is possible to: 
- produce seamless confocal and wide-field panoramas of tissue sections, embryos or isolated 
cells. The high throughput digitization of biological material is the prerequisite of virtual 
microscopy. 
- perform quantitative analysis of thousands of cells growing sparsely or in monolayers on 
microscopes slides or on 384-well plates 
 
Our automated microscopy method has been applied in several different research projects 
(see related publications). The work presented in this thesis illustrated two types of projects 
that would not have been possible to carry out without this technique: 
i) characterization of drug sensitivity profiles of tumor cells and to measure the effect of anti-
cancer drugs on immune effector cells (Paper III and IV) 
ii) measuring the effect of a large panel of human fibroblasts on the proliferation of tumor 
cells in mixed cell cultures (Paper V and Paper VI) 
 
The two drug sensitivity studies laid the ground for an extensive ongoing project that aims to 
provide tools for assay guided individualized treatment of cancer patients. We have 
developed an assay for primary tumor cells (iVV – in vitro viability assay), which addresses 
many of the shortcomings and limitations of the previous drug sensitivity assays. Using 
custom built hardware and our own capturing and analysis software, we have managed to 
create a robust, reliable and affordable system. During the past five years, our group has 
carried out almost 500 drug sensitivity tests on primary tumor cells, with a minimum of 30 
different drugs.  
 
In summary, this method allowed us to draw three simple conclusions (Figure 2.7 – 2.8): 
(i) there are no drugs that work on all tumors, (ii) all drugs can be effective against certain 
tumors and (iii) very resistant tumors can still be sensitive for a few drugs. 
 
In the future, the assay will also be adapted to test sensitivity of solid tumors. It will be used 
to explore the possibility to find suitable tumor targets for newly developed anti-cancer 
drugs.  The assay may also provide new possibilities for patient pre-selection in clinical trials 
both for new drugs, or for new use of already licensed drugs. 
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The introduction of high throughput time-lapse imaging of mixed cell cultures opened up 
new ways to study tumor–effector interactions in a parallel fashion. The use of chemical or 
genetic fluorescence labels to identify the target cells at the beginning and at the end of the 
experiment allowed us to collect quantitative information about cell viability and proliferation 
rates even when working at low cell numbers or analysing heterogeneous populations. This 
experimental set-up permitted us to revisit some old questions concerning 
microenvironmental control of tumor cell growth. Even though “Paget’s seed and soil 
hypothesis” dates back to 1889, the molecular determinants of the seed are still much better 
understood than those of the soil” (Fidler 2003; Mueller and Fusenig 2004). Almost 50 years 
have elapsed since Michael Woodruff reported on an exceptional patient that indicated the 
existence of some radiosensitive microenvironmental control of dormant tumor cells 
(Woodruff 1982). Furthermore, it was 45 years ago that Michael Stoker provided 
experimental evidence that normal murine fibroblasts can interfere with the proliferation of 
their transformed derivatives (Stoker 1964; Stoker, Shearer et al. 1966). But only now can we 
address, with the help of new technologies, the possible mechanism behind the 
phenomenon. 
 
Concerning the relevance of the in vitro observed fibroblast mediated tumor growth inhibition 
many questions remains to be answered: 
- how is the contact dependent inhibition mediated? 
- is there analogous inhibitory effect in vivo? 
  
 • if YES - Is there any difference between individuals in their capacity 
to suppress tumor cell growth through microenvironmental control? 
 • if YES - How can it be measured most effectively? 
 • if YES - Is it possible to boost it pharmacologically in cancer patients 
to prevent additional spreading of the tumor? Can it be boosted as a preventive 
measure in individuals with high tumor risk?  
 
Is our in vitro co-culture system sensitive enough to design assays that can identify the 
molecular mechanism that control the fibroblast mediated inhibition or to use it to identify 
pharmacological agents that can enhance its activity? 
 
The introduction of microscopy into classical biology was groundbreaking and ever since, 
each new type of microscopy technique has contributed to big steps in the understanding 
of biology. The advent of automated microscopy techniques, into selected laboratories, in 
combination with the computational power of almost any computer today, already 
represents giant leaps in the field of visualizing biology.  
 
This thesis has illustrated that the combination of available and affordable techniques allowed 
us to carry out microscopy experiments that were previously only possible to do in 
specialized high throughput image facilities or in the pharmaceutical industry. 
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6.1	   PRIMARY	  FIBROBLAST	  CULTURES	  –	  TRICKS	  AND	  TIPS	  
Primary fibroblast cultures were established from mechanically dissociated tissue pieces. 
Tissue from surgical rest materials, prostate fine needle biopsies and skin punch biopsies 
were transported form the clinics, overnight at room temperature, in Iscove’s modified 
Dulbecco´s medium (IMDM) supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) and penicillin, streptomycin and gentamicin at 100, 100 and 50 µg/mL concentration, 
respectively (PSG additive). Upon arrival the material was rinsed in phosphate buffered saline 
(PBS). Surgical rest materials and skin biopsies were put through 2 or 3 washes of PBS to be 
cleaned sufficiently. Transferring the pieces to new culture dishes containing PBS most easily 
does washing. Using a sterile surgical blade and forceps the tissue was gently cut into smaller 
pieces and forced to adhere to thin scratches made in the plastic bottom of the dish (3.5, 6 or 
10 cm culture dish). It is wise to divide the material in at least two separate dishes, to prevent 
entire loss if fungus or bacteria infect one dish. To prevent the material from floating around 
during the dissociation and adherence procedure, only a drop of medium should cover the 
tissue pieces. At the end, 2-10 ml culture medium (IMDM, 10-20% FBS, PSG) should 
carefully be added to the dish so as not to dislodge the pieces from the plastic surface. It is 
optimal to store the dishes in a plastic box in the incubator, without moving it around or 
changing the medium for 4-5 days. The first cells should be seen within 10-14 days of 
culturing. 
 
To improve the expansion of very small islands of outgrowths or sparsely and slowly growing 
cells the IMDM medium could be supplemented with fibroblast growth medium (FGM, 
including fibroblast growth supplements (FGS)) in 4:1 ratio of IMDM:FGM, 10-20% FBS, 
PSG. To prevent apoptosis induced by oxidative stress at low cell density, the medium could 
also be enriched with the antioxidant mix of sodium pyruvate, α-thioglycerol and 
bathocuproine disulfonate (Brielmeier, Bechet et al. 1998). 
 
 
6.2	   PROGRAMMING	  IN	  OPENLAB	  AUTOMATOR	  –	  NUTS	  AND	  BOLTS	  
We have used the visual programming environment of OpenlabAutomator to develop 
programs for automated image capture and image analysis. The concept of visual 
programming, with icons inked into flowcharts is illustrated below by the Moving-Z capture 
loop and Get automator time loop (Figure 6.2.1-6.2.2). Figure 6.2.3 A-C show bird-eye-view 
images of the three programs developed in this thesis; QuantCapture 4.0, QuantCount 3.0 
and CytotoxCount 3.0. 
 
Moving Z-capture loop: 
The true (T) or false (F) icon contains an if-statement for a certain wavelength of 
illumination. If the user has preset an exposure time for this wavelength the statement does 
not equals zero and the statement is therefore true and T-links will direct the flow into the 
loop of the moving Z capture. If it is zero, meaning that this wavelength is not included in 
the capture the statement is regarded as false and the F-link take the command to the next 
T/F-wavelength icon (Figure 6.2.1). If selected, the loop will open the shutter and move the 
z-stage simultaneously for the length of time defined by “get automator-time”-loop. 
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Figure 6.2.1  Moving Z-capture loop 
 
 
Quantcapture_4 - Get automator time & capture Dark background 
 
Synchronization loop: The Moving Z-capture requires the exposure time of the camera to be 
precisely synchronized with the time it takes to move through the Z-stack. This time is 
dependent on sample z-thickness, number of z-steps and the exposure for different 
wavelengths. A dummy capture calculates the exposure time plus the travel time and capture 
simultaneously a “dark background” image (using closed shutters) for the total exposure time 
(inclusive Z-travel). This “dark background” image will later be re-used to subtract camera 




Figure 6.2.2 Get automator-time loop 
 
	  
6.3	   IMAGE	  PROCESSING/ANALYSIS	  -­	  COMMENTS	  
There is no general “theory” of image enhancement. When an image is processed for visual 
interpretation, the viewer is the ultimate judge of how well a particular method works 
(Gonzalez and Woods 2008). This is important to remember in image processing, because 
with freedom comes responsibility. Any change made to the image must be applied 
uniformly to the whole image and to all images inside the image-stack/experiment, including 
controls. Changes must be documented and the original raw image must always be saved, in a 
lossless file format. Reviewers always have the right to claim visual inspection of original, raw 
image files. 
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       Figure 6.2.3 
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         C 
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